Clinical Study to Evaluate the Body Fat Reducing Effects of Heat-Treated Green Tea Extract Complex
NCT ID: NCT06609603
Last Updated: 2024-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2023-11-17
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts
NCT04850352
The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone Peptides
NCT02147041
The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial
NCT00383058
A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -
NCT02651454
The Effect of「GTT-EGCG」on Acne Women
NCT01846338
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HTGT compound
* Dietary supplement: HTGT compound
* oral administration of HTGT compound once daily, 2 capsules per day.
* Dietary supplement; Placebo
* oral administration of placebo once daily, 2 canpules per day
HTGT compound
oral administration of HTGT compound once daily
Placebo
Once daily, 2 capsules per day
Placebo
Oral administration of placebo once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HTGT compound
oral administration of HTGT compound once daily
Placebo
Oral administration of placebo once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 25.0 \~ 34.9 kg/m\^2
* Waist circumferebce: 90cm or more for men, 85cm or more for women
* Subjects who have fully understand the information provided about the study and voluntarily decided to participate
Exclusion Criteria
* Individuals participated in a commercial weight loss program within 3 months prior to Visit 1
* Participants who have undergone surgical procedures within 3 years
* Participants who have taken obesity treatment medications within the last 3 months
* Individuals who have taken medications affecting weight or dietary supplements for weight control within the last month
* Subjects with uncontrolled hypertension
* Subjects diagnosed with diabetes
* TSH \<0.1 uIU/ml or \>10 uIU/ml
* Creatinine \>1.5mg/dL
* AST or ALT \> three times the upper normal limit
19 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amorepacific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sang-Wook Song, M.D./Ph.D
Role: PRINCIPAL_INVESTIGATOR
Catholic University St. Vincent Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Catholic University St. Vincent Hospital
Suwon, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
HyunJin Nam, Ph.D.
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP-PV-2023-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.